← Leaderboards
Richard Davey
Niaid Extramural Activities
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Niaid Extramural Activities
Same institution · by research overlap
- Peter Mannon$881,750
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchPharmaceutical PreparationsImmunologicsInfectionRandomizedEnrollmentLaboratoriesBaseAcuteDoseClinical TrialsRandomized Clinical TrialsInternationalCountryPreventSafetyProtocols DocumentationInfluenzaInfluenza A Virus, H5n1 SubtypeInvestigationNational Institute Of Allergy And Infectious DiseaseSiteBirdsDouble-Blind Method
Grant awards (40)
Influenza and Emerging Infectious Diseases$3,655,513
ZIA · FY2025 · AI · contact PI
Influenza and Emerging Infectious Diseases$4,224,059
ZIA · FY2024 · AI · contact PI
Influenza and Emerging Infectious Diseases$3,718,933
ZIA · FY2023 · AI · contact PI
Influenza and Emerging Infectious Diseases$3,483,874
ZIA · FY2022 · AI · contact PI
Influenza and Emerging Infectious Diseases$3,113,196
ZIA · FY2021 · AI · contact PI
Influenza and Emerging Infectious Diseases$3,504,680
ZIA · FY2020 · AI · contact PI
International Observational Study to Characterize Adults Hospitalized with Complications of influenza Hospitalization Study (FLU 003 Plus) Portion of Study Expanded to Include COVID-19 Patients$3,487,152
ZIA · FY2020 · AI · contact PI
Influenza and Emerging Infectious Diseases$3,109,509
ZIA · FY2019 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$345,501
ZIA · FY2019 · AI · contact PI
Influenza and Emerging Infectious Diseases$2,632,754
ZIA · FY2018 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$292,528
ZIA · FY2018 · AI · contact PI
Influenza and Emerging Infectious Diseases$2,632,949
ZIA · FY2017 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$292,550
ZIA · FY2017 · AI · contact PI
Influenza and Emerging Infectious Diseases$2,420,158
ZIA · FY2016 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$605,039
ZIA · FY2016 · AI · contact PI
Influenza and Emerging Infectious Diseases$2,412,678
ZIA · FY2015 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$603,170
ZIA · FY2015 · AI · contact PI
Influenza and Emerging Infectious Diseases$2,058,761
ZIA · FY2014 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$514,690
ZIA · FY2014 · AI · contact PI
Influenza and Emerging Infectious Diseases$2,009,368
ZIA · FY2013 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$502,342
ZIA · FY2013 · AI · contact PI
Influenza and Emerging Infectious Diseases$1,840,538
ZIA · FY2012 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$448,296
ZIA · FY2012 · AI · contact PI
Influenza and Emerging Infectious Diseases$1,528,179
ZIA · FY2011 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$1,248,773
ZIA · FY2011 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$2,036,447
ZIA · FY2010 · AI · contact PI
Influenza and Emerging Infectious Diseases$791,726
ZIA · FY2010 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$1,930,972
ZIA · FY2009 · AI · contact PI
Influenza and Emerging Infectious Diseases$958,408
ZIA · FY2009 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$2,059,757
Z01 · FY2008 · AI · contact PI
Influenza and Emerging Infectious Diseases$917,122
Z01 · FY2008 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeutics$2,513,865
Z01 · FY2007 · AI · contact PI
Influenza and Emerging Infectious Diseases$1,094,375
Z01 · FY2007 · AI · contact PI
Immunologic And Virologic Approaches To HIV-1 Therapeuti$0
Z01 · FY2006 · AI · contact PI
Immunologic/Virologic Approaches To HIV-1 Therapeutics$0
Z01 · FY2005 · AI
Immunologic And Virologic Approaches To HIV-1 Therapeuti$0
Z01 · FY2004 · AI
Immunologic And Virologic Approaches To HIV-1 Therapeuti$0
Z01 · FY2003 · AI
Immunologic And Virologic Approaches To Hiv-1 Therapeuti$0
Z01 · FY2002 · AI
Immunologic &Virologic Approaches To HIV 1 Therapeutics$0
Z01 · FY2001 · AI
IMMUNOLOGIC AND VIROLOGIC APPROACHES TO HIV1 THERAPEUTIC$0
Z01 · FY2000 · AI